coronavirus update indiaas on : 28 October 2020 04:51 GMT+5:30
"Does Centre Have Rs 80,000 Crore To Give Buy And Give Each Indian COVID-19 Vaccine",Ask Adar Poonawalla
During his Independence Day speech last month, Prime Minister Narendra Modi said that when a viable vaccine was ready the government had a plan to ensure that it reached every Indian.
"Does Centre Have Rs 80,000 Crore To Give Buy And Give Each Indian COVID-19 Vaccine", Ask Adar Poonawalla
New Delhi: Chairman Of Pune-based Serum Institute Of India(SII) Adar Poonawalla took to Twitter to question the Ministry of Health on Saturday.
The SII has partnered with the University of Oxford and AstraZeneca for the manufacturing and distribution of its coronavirus vaccine candidate in India
"Quick question: will the Government of India have 80,000 crores available over the next year? Because that is what the Ministry of Health needs to buy and distribute the vaccine to everyone in India. This is the next concerning challenge we need to tackle," Mr. Poonawalla said.
"I ask this question because we need to plan and guide, vaccine manufacturers both in India and overseas to service the needs of our country in terms of procurement and distribution," he added.
I ask this question, because we need to plan and guide, vaccine manufacturers both in India and overseas to service the needs of our country in terms of procurement and distribution.— Adar Poonawalla (@adarpoonawalla) September 26, 2020
The Clinical trials for Covidshield the vaccine developed by the University of Oxford and AstraZeneca in collaboration with the SII have begun in Mumbai's KEM and Nair hospitals. They are likely to begin at a state-run hospital in Pune in sometimes in the coming week.
The DGCI earlier had this month revoked its order suspending any new recruitment for the phase-2 and phase-3 of the clinical trial of the Covisheild.
This process was done across the globe after one of the volunteers who received the vaccine experienced spinal inflammation.
"As I'd mentioned earlier, we should not jump to conclusions until the trials are fully concluded. The recent chain of events are a clear example why we should not bias the process and should respect the process till the end. Good news, @UniofOxford," Adar Poonawalla had said after the revocation of DGCI's order.